Effektivnost' primeneniya preparata Lavenum® u bol'nykh varikoznoy bolezn'yu, perenesshikh venektomiyu nizhnikh konechnostey


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article presents the results of the study involving 24 patients who underwent phlebectomy for the primary varicose veins of the lower limbs. Of these, Lavenum® gel was applied on the area of affected vein in 12 patients on 2 nd day after surgery for 14 days 2-3 times a day. Based on the data of the study, rationale for the use of the gel and the scheme of the use of Lavenum in the postoperative period after phlebectomy of lower extremities are provided. The clinical, physiological and laboratory results demonstrating the effectiveness of use of the gel are presented.

Texto integral

Acesso é fechado

Bibliografia

  1. Эмануэл В.Л., Гриценко В.В. Лабораторный контроль антикоагулянтной терапии у хирургических больных. Методические рекомендации. СПб., 2002.
  2. Шилов А.М., Мельник М.В. Тиклин в профилактике и лечении сердечнососудистых заболеваний // Рос. мед. вести 2003. № 4. C. 42.
  3. Шиффман Ф.Д. Патофизиология крови. Пер. с англ. М., 2000. C. 191-82.
  4. Butchart EG, Bodnar E. Trombosis, embolism and bliding. London, ICR Pablisher 1992: 123-72.
  5. Mehta S, Ysuf S, Peters R, et all. Effects of pretreatment with clopidogrel and aspirin fallowed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527.
  6. The Assessment of the Safety and Efficacy of a New Thrombolytc Regimen. (ASSENT) -3 investigators. Efficacy and safety of tenecteplase in comination with enoxaparine, aboximab or unfractionated heparin: the ASSENT - 3 randomised trial in acute myocardial infarction. Lancet 2001; 358:605.
  7. Основы клинической флебологии / Под ред. Ю.Л. Шевченко, Ю.М. Стойко, М.И. Лыткина. М., 2005. 246 c.
  8. Комов В.П. Биохимия. М., 2004. 638 с.
  9. Nighttingel SL. Appropriate use of low molecular weight heparins (LMWH). JAMA 2003;270:1672-76.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2013

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies